LiveRamp price target raised to $55 from $50 at Craig-Hallum

Craig-Hallum raised the firm’s price target on LiveRamp to $55 from $50 and keeps a Buy rating on the shares. LiveRamp’s results were in-line with preliminary figures, and the company continues to drive execution improvements across the business, with sales team trends continuing to improve, margin gains continuing, and growth in key metrics like ARR and RPO, the analyst tells investors in a research note. LiveRamp is uniquely positioned to benefit from cookie deprecation, which should be a tailwind for new logos and cross/upsells.